Abstract

This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call